MedTrace Logo

Long Term Follow Up to Determine the Effects of Collagenase SANTYL Ointment on Scar Formation

NCT01705860 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 12

Last updated 2013-04-15

No results posted yet for this study

Summary

The present study will evaluate the long term effects on scar formation for dermatome-induced skin wounds treated with Collagenase Santyl® Ointment or vehicle (white petrolatum ointment) alone. The previous study, 017-101-09-001, utilized a small, experimental, cutaneous wound to evaluate both time to complete wound closure and quality of the resulting scar when Collagenase Santyl® Ointment was used to treat the wound.

Conditions

  • Follow up to Acute Wound Scar Study

Interventions

BIOLOGICAL

Santyl

Sponsors & Collaborators

  • Healthpoint

    lead INDUSTRY

Principal Investigators

  • Herbert B Slade, MD · Healthpoint

  • Shai Rozen, MD · University of Texas Southwestern Medical Center

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2013-02-28
Completion
2013-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01705860 on ClinicalTrials.gov